Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021
DESCRIPTION Epidermolysis Bullosa (EB) is a condition in which the skin becomes extremely fragile causing blisters from minor rubbing or a small injury. It is mostly a genetic disease that is commonly seen in children. In the case of severe EB, blisters are not confined to the outer skin and may develop in places like linings of the mouth, esophagus, stomach, intestines, upper airway, bladder, and genitals. The Epidermolysis Bullosa care and treatment market has significant potential in the years ahead given the various acquisitions that have taken place and a robust drugs pipeline. Geographically, the United States and Japan are expected to be a major market for EB care and treatment, attributable to high awareness and prevalence of the disease coupled with a wellestablished healthcare landscape in both these regions. Research Methodology This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report. Industry Overview In this section, the entire Epidermolysis Bullosa Care and Treatment market is explained along with the causes, diagnosis, and prevention of the disease, the various drivers, restraints and opportunities to the market and the prevalence of the disease based on age, gender and region. A product pipeline of various drugs and vaccines for therapeutic action have been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis. Segmentation Epidermolysis Bullosa Care and Treatment market has been segmented based on the type and geography as below:  By Type o Epidermolysis Bullosa Care Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021
o Pharmacological Drugs o Surgical Treatment o Pipeline Therapies By Geography o Americas
North America
South America
o Europe Middle East and Africa
Europe
Middle East and Africa
o Asia Pacific Market Players This section deals with major players in the market, their market shares, products, growth strategies, financials, and recent investments among others. Key industry players profiled in the report are RegeneRx Biopharma, InMed Pharmaceuticals Inc, Amicus Therapeutics, and TWi Pharmaceuticals, Inc. among others.
Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021
TABLE OF CONTENTS 1. Introduction 2. Research Methodology 3. Executive Summary 4. Epidermolysis Bullosa Industry Overview 4.1. Market Overview 4.2. Drivers, Restraints, and Opportunities 4.3. Industry Value Chain Analysis 4.4. Prevalence 4.4.1. By Age Group 4.4.2. By Gender 4.4.3. By Region 4.5. Product Pipeline 4.6. Innovations 4.7. Industry Regulations 4.8. Scenario Analysis 5. Epidermolysis Bullosa Care and Treatment Market Forecast by Type (US$ million) 5.1. Epidermolysis Bullosa Care 5.2. Pharmacological Drugs 5.3. Surgical Treatment 5.4. Pipeline Therapies 6. Epidermolysis Bullosa Care and Treatment Market Forecast by Geography (US$ million) 6.1. Americas 6.1.1. North America 6.1.2. South America 6.2. Europe Middle East and Africa 6.2.1. Europe 6.2.2. Middle East and Africa 6.3. Asia Pacific 7. Competitive Intelligence 7.1. Market Share Analysis Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021
7.2. Investment Analysis 7.3. Recent Deals 7.4. Strategies of Key Players 8. Company Profiles 8.1. RegeneRx Biopharma 8.2. InMed Pharmaceuticals Inc 8.3. Amicus Therapeutics 8.4. TWi Pharmaceuticals, Inc 8.5. Ember Therapeutics 8.6. Abeona Therapeutics
Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021
TO ORDER OR REQUEST FOR A SAMPLE: Product: Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021 Link:https://www.knowledge-sourcing.com/products/epidermolysis-bullosa-care-andtreatment-market-forecasts-from-2016-to-2021 SKU: KSI0615348 Price: US$3,200 – Single User License US$5,200 – Multi User License US$7,200 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment For wire transfer, write to us at sales@knowledge-sourcing.com
For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-866-714-4587
Epidermolysis Bullosa Care and Treatment Market – Forecasts from 2016 to 2021